Filing Details
- Accession Number:
- 0000899243-20-018278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-02 16:19:30
- Reporting Period:
- 2020-07-01
- Accepted Time:
- 2020-07-02 16:19:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1680581 | Fulcrum Therapeutics Inc. | FULC | Pharmaceutical Preparations (2834) | 474839948 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1778713 | Diego Cadavid | C/O Fulcrum Therapeutics, Inc. 26 Landsdowne Street Cambridge MA 02139 | Svp Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-01 | 1,071 | $18.30 | 65,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019.
Billionaire Hedge Funds
